Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Disparities in Neurotoxicity Risk and Outcomes among Pediatric Acute Lymphoblastic Leukemia Patients.

Taylor OA, Brown AL, Brackett J, Dreyer ZE, Moore IK, Mitby P, Hooke MC, Hockenberry MJ, Lupo PJ, Scheurer ME.

Clin Cancer Res. 2018 Sep 11. doi: 10.1158/1078-0432.CCR-18-0939. [Epub ahead of print]

PMID:
30206159
2.

50 Years Ago in The Journal of Pediatrics: Prevention and Management of Acute Hyperuricemia in Childhood Leukemia.

Heikamp E, Dreyer ZE.

J Pediatr. 2017 Dec;191:178. doi: 10.1016/j.jpeds.2017.09.041. No abstract available.

PMID:
29173302
3.

Comparison of height and weight after 12 vs. 18 Gy cranial radiation therapy in pediatric acute lymphoblastic leukemia (ALL) patients.

Chen AC, Okcu MF, Dreyer ZE, Kamdar KY, Sonabend RY, Suzawa HS, Jo E, Paulino AC.

Adv Radiat Oncol. 2017 Feb 1;2(2):228-234. doi: 10.1016/j.adro.2017.01.010. eCollection 2017 Apr-Jun.

4.

Deliberate liver transplantation for fulminant liver failure with acute lymphoblastic leukemia.

Kueht ML, Cotton RT, Godfrey EL, Dreyer ZE, Fishman DS, Goss JA.

Liver Transpl. 2016 Dec;22(12):1724-1726. doi: 10.1002/lt.24627. No abstract available.

5.

A Pilot Study of Intensified PEG-Asparaginase in High-risk Acute Lymphoblastic Leukemia: Children's Oncology Group Study AALL08P1.

Rodriguez V, Kairalla J, Salzer WL, Raetz EA, Loh ML, Carroll AJ, Heerema NA, Wood BL, Borowitz MJ, Burke MJ, Asselin BL, Devidas M, Winick NJ, Carroll WL, Hunger SP, Dreyer ZE.

J Pediatr Hematol Oncol. 2016 Aug;38(6):409-17. doi: 10.1097/MPH.0000000000000589.

6.

CELF4 Variant and Anthracycline-Related Cardiomyopathy: A Children's Oncology Group Genome-Wide Association Study.

Wang X, Sun CL, Quiñones-Lombraña A, Singh P, Landier W, Hageman L, Mather M, Rotter JI, Taylor KD, Chen YD, Armenian SH, Winick N, Ginsberg JP, Neglia JP, Oeffinger KC, Castellino SM, Dreyer ZE, Hudson MM, Robison LL, Blanco JG, Bhatia S.

J Clin Oncol. 2016 Mar 10;34(8):863-70. doi: 10.1200/JCO.2015.63.4550. Epub 2016 Jan 25.

7.

Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli-Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia.

Vrooman LM, Kirov II, Dreyer ZE, Kelly M, Hijiya N, Brown P, Drachtman RA, Messinger YH, Ritchey AK, Hale GA, Maloney K, Lu Y, Plourde PV, Silverman LB.

Pediatr Blood Cancer. 2016 Feb;63(2):228-33. doi: 10.1002/pbc.25757. Epub 2015 Sep 16.

8.

Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology Group.

Salzer WL, Jones TL, Devidas M, Dreyer ZE, Gore L, Winick NJ, Sung L, Raetz E, Loh ML, Wang CY, De Lorenzo P, Valsecchi MG, Pieters R, Carroll WL, Hunger SP, Hilden JM, Brown P.

Pediatr Blood Cancer. 2015 Mar;62(3):414-8. doi: 10.1002/pbc.25311. Epub 2014 Nov 18.

9.

Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (Cohort 3).

Dreyer ZE, Hilden JM, Jones TL, Devidas M, Winick NJ, Willman CL, Harvey RC, Chen IM, Behm FG, Pullen J, Wood BL, Carroll AJ, Heerema NA, Felix CA, Robinson B, Reaman GH, Salzer WL, Hunger SP, Carroll WL, Camitta BM.

Pediatr Blood Cancer. 2015 Mar;62(3):419-26. doi: 10.1002/pbc.25322. Epub 2014 Nov 14.

10.

Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: a report from the children's oncology group.

Wang X, Liu W, Sun CL, Armenian SH, Hakonarson H, Hageman L, Ding Y, Landier W, Blanco JG, Chen L, Quiñones A, Ferguson D, Winick N, Ginsberg JP, Keller F, Neglia JP, Desai S, Sklar CA, Castellino SM, Cherrick I, Dreyer ZE, Hudson MM, Robison LL, Yasui Y, Relling MV, Bhatia S.

J Clin Oncol. 2014 Mar 1;32(7):647-53. doi: 10.1200/JCO.2013.50.3557. Epub 2014 Jan 27.

11.

Safety profile of asparaginase Erwinia chrysanthemi in a large compassionate-use trial.

Plourde PV, Jeha S, Hijiya N, Keller FG, Silverman LB, Rheingold SR, Dreyer ZE, Dahl GV, Mercedes T, Lai C, Corn T.

Pediatr Blood Cancer. 2014 Jul;61(7):1232-8. doi: 10.1002/pbc.24938. Epub 2014 Jan 16.

12.

Cytogenetics and outcome of infants with acute lymphoblastic leukemia and absence of MLL rearrangements.

De Lorenzo P, Moorman AV, Pieters R, Dreyer ZE, Heerema NA, Carroll AJ, Hunger SP, Harvey R, Willman CL, Devidas M, Valsecchi MG, Harrison CJ.

Leukemia. 2014 Feb;28(2):428-30. doi: 10.1038/leu.2013.280. Epub 2013 Sep 27. No abstract available.

13.

Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia.

Urtishak KA, Edwards AY, Wang LS, Hudome A, Robinson BW, Barrett JS, Cao K, Cory L, Moore JS, Bantly AD, Yu QC, Chen IM, Atlas SR, Willman CL, Kundu M, Carroll AJ, Heerema NA, Devidas M, Hilden JM, Dreyer ZE, Hunger SP, Reaman GH, Felix CA.

Blood. 2013 Apr 4;121(14):2689-703. doi: 10.1182/blood-2012-04-425033. Epub 2013 Feb 7.

14.

Identification of TP53 as an acute lymphocytic leukemia susceptibility gene through exome sequencing.

Powell BC, Jiang L, Muzny DM, Treviño LR, Dreyer ZE, Strong LC, Wheeler DA, Gibbs RA, Plon SE.

Pediatr Blood Cancer. 2013 Jun;60(6):E1-3. doi: 10.1002/pbc.24417. Epub 2012 Dec 19.

15.

Human papillomavirus vaccination in female pediatric cancer survivors.

Hoffman L, Okcu MF, Dreyer ZE, Suzawa H, Bryant R, Middleman AB.

J Pediatr Adolesc Gynecol. 2012 Oct;25(5):305-7. doi: 10.1016/j.jpag.2012.05.004. Epub 2012 Jul 24.

PMID:
22831900
16.

Modifications to induction therapy decrease risk of early death in infants with acute lymphoblastic leukemia treated on Children's Oncology Group P9407.

Salzer WL, Jones TL, Devidas M, Hilden JM, Winick N, Hunger S, Carroll WL, Camitta B, Dreyer ZE.

Pediatr Blood Cancer. 2012 Nov;59(5):834-9. doi: 10.1002/pbc.24132. Epub 2012 Apr 5.

17.

Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study.

Kang H, Wilson CS, Harvey RC, Chen IM, Murphy MH, Atlas SR, Bedrick EJ, Devidas M, Carroll AJ, Robinson BW, Stam RW, Valsecchi MG, Pieters R, Heerema NA, Hilden JM, Felix CA, Reaman GH, Camitta B, Winick N, Carroll WL, Dreyer ZE, Hunger SP, Willman CL.

Blood. 2012 Feb 23;119(8):1872-81. doi: 10.1182/blood-2011-10-382861. Epub 2011 Dec 30.

18.

Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.

Vogelzang NJ, Benowitz SI, Adams S, Aghajanian C, Chang SM, Dreyer ZE, Janne PA, Ko AH, Masters GA, Odenike O, Patel JD, Roth BJ, Samlowski WE, Seidman AD, Tap WD, Temel JS, Von Roenn JH, Kris MG.

J Clin Oncol. 2012 Jan 1;30(1):88-109. doi: 10.1200/JCO.2011.40.1919. Epub 2011 Dec 5.

PMID:
22147736
19.

A meta-analysis of MTHFR C677T and A1298C polymorphisms and risk of acute lymphoblastic leukemia in children.

Yan J, Yin M, Dreyer ZE, Scheurer ME, Kamdar K, Wei Q, Okcu MF.

Pediatr Blood Cancer. 2012 Apr;58(4):513-8. doi: 10.1002/pbc.23137. Epub 2011 Apr 14. Review.

PMID:
21495160
20.

Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and MLL gene rearrangements: a report from the Children's Oncology Group.

Dreyer ZE, Dinndorf PA, Camitta B, Sather H, La MK, Devidas M, Hilden JM, Heerema NA, Sanders JE, McGlennen R, Willman CL, Carroll AJ, Behm F, Smith FO, Woods WG, Godder K, Reaman GH.

J Clin Oncol. 2011 Jan 10;29(2):214-22. doi: 10.1200/JCO.2009.26.8938. Epub 2010 Dec 6.

21.

Molecular monitoring of 8p11 myeloproliferative syndrome in an infant.

Zhang WW, Habeebu S, Sheehan AM, Naeem R, Hernandez VS, Dreyer ZE, López-Terrada D.

J Pediatr Hematol Oncol. 2009 Nov;31(11):879-83. doi: 10.1097/MPH.0b013e3181b83fd0.

PMID:
19829149
22.

Follow-up into adulthood is critically important for survivors of pediatric transplant.

Dreyer ZE.

Bone Marrow Transplant. 2009 Mar;43(6):433. doi: 10.1038/bmt.2008.362. No abstract available.

PMID:
19325531
23.

Overexpression of ZNF342 by juxtaposition with MPO promoter/enhancer in the novel translocation t(17;19)(q23;q13.32) in pediatric acute myeloid leukemia and analysis of ZNF342 expression in leukemia.

Poland KS, Shardy DL, Azim M, Naeem R, Krance RA, Dreyer ZE, Neeley ES, Zhang N, Qiu YH, Kornblau SM, Plon SE.

Genes Chromosomes Cancer. 2009 Jun;48(6):480-9. doi: 10.1002/gcc.20654.

24.

Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemia.

Thompson PA, Murry DJ, Rosner GL, Lunagomez S, Blaney SM, Berg SL, Camitta BM, Dreyer ZE, Bomgaars LR.

Cancer Chemother Pharmacol. 2007 May;59(6):847-53. Epub 2006 Nov 29.

PMID:
17136402
25.

Initial approach to the child who presents with sickle-cell disease and fever.

Dreyer ZE.

Semin Pediatr Infect Dis. 1995 Oct;6(4):232-6. No abstract available.

PMID:
16731353
26.

Conservative surgical treatment of a profoundly immunosuppressed pediatric patient with Boerhaave syndrome.

Lee TC, Dreyer ZE, Brandt ML.

J Pediatr Hematol Oncol. 2005 Nov;27(11):616-7.

PMID:
16282895
27.

Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study.

Perkins JL, Liu Y, Mitby PA, Neglia JP, Hammond S, Stovall M, Meadows AT, Hutchinson R, Dreyer ZE, Robison LL, Mertens AC.

J Clin Oncol. 2005 Jun 1;23(16):3733-41.

PMID:
15923570
28.

Phase 2 study of idarubicin in pediatric brain tumors: Pediatric Oncology Group study POG 9237.

Dreyer ZE, Kadota RP, Stewart CF, Friedman HS, Mahoney DH, Kun LE, McCluggage CW, Burger PC, Kepner J, Heideman RL; Pediatric Oncology Group.

Neuro Oncol. 2003 Oct;5(4):261-7.

29.
30.

Design and analysis of epidemiological studies of excess cancer among children exposed to Chernobyl radionuclides.

Peterson LE, Dreyer ZE, Plon SE, Smith JL, Weinberg AD, McCarthy PL.

Stem Cells. 1997;15 Suppl 2:211-30.

31.

Chest infections and syndromes in sickle cell disease of childhood.

Dreyer ZE.

Semin Respir Infect. 1996 Sep;11(3):163-72. Review.

PMID:
8883174
32.

Renal venous thrombosis complicating acute myeloid leukemia with hyperleukocytosis.

Murray JC, Dorfman SR, Brandt ML, Dreyer ZE.

J Pediatr Hematol Oncol. 1996 Aug;18(3):327-30.

PMID:
8689355
33.

Atypical cytogenic aberrations in two childhood peripheral primitive neuroectodermal tumors.

Murray JC, Langston C, Dreyer ZE, Stephenson CT, Pokorny WJ, Horowitz ME, Cooley LD.

Genes Chromosomes Cancer. 1995 Feb;12(2):142-7.

PMID:
7535087
34.

Isolated bone relapse during hematologic remission in childhood acute lymphoblastic leukemia: report of a metatarsal relapse and review of the literature.

Murray JC, Gmoser DJ, Barnes DA, Oshman D, Hawkins HK, Gresik MV, Dreyer ZE.

Med Pediatr Oncol. 1994;23(2):153-7. Review.

PMID:
8202041
35.

Hodgkin's disease associated with central pontine myelinolysis.

Chintagumpala MM, Mahoney DH Jr, McClain K, Dreyer ZE, Fishman MA, Carrol CL, Steuber CP.

Med Pediatr Oncol. 1993;21(4):311-4.

PMID:
7682285
36.

Infection-associated hemophagocytic syndrome. Evidence for Epstein-Barr virus gene expression.

Dreyer ZE, Dowell BL, Chen H, Hawkins E, McClain KL.

Am J Pediatr Hematol Oncol. 1991 Winter;13(4):476-81.

PMID:
1664662

Supplemental Content

Loading ...
Support Center